会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • 2-HALO-5-ALKYNYL-PYRIDYL NICOTINIC LIGANDS
    • 2-羟基-5-烷基 - 吡啶基尼古丁配体
    • WO2014160783A1
    • 2014-10-02
    • PCT/US2014/031873
    • 2014-03-26
    • GEORGETOWN UNIVERSITY
    • XIAO, YingxianKELLAR, Kenneth, J.BROWN, Milton, L.PAIGE, Mikell, A.LIU, Yong
    • A61K31/44A61K31/397C07D205/02
    • C07D401/12
    • Disclosed are heterocyclic compounds that are ligands for nicotinic acetylcholine receptors. The compounds are useful for treating a mammal suffering from any one of a range of therapeutic indications, including Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder, chemical substance abuse, alcoholism, memory deficit, pseudodementia, Ganser's syndrome, migraine pain, bulimia, obesity, premenstrual syndrome or late luteal phase syndrome, tobacco abuse, post-traumatic syndrome, social phobia, chronic fatigue syndrome, premature ejaculation, erectile difficulty, anorexia nervosa, disorders of sleep, autism, mutism, trichotillomania, and hypothermia.
    • 公开了作为烟碱乙酰胆碱受体配体的杂环化合物。 该化合物可用于治疗患有一系列治疗适应症,包括阿尔茨海默病,帕金森病,运动障碍,图雷特综合征,精神分裂症,注意力缺陷障碍,焦虑症,疼痛,抑郁症,强迫症,化学物质滥用 酒精中毒,记忆缺陷,假性痴呆,甘ser综合征,偏头痛,贪食症,肥胖症,经前期综合征或晚期黄体期综合征,烟草滥用,创伤后综合征,社交恐惧症,慢性疲劳综合征,早泄,勃起障碍,神经性厌食症, 睡眠障碍,孤独症,多发症,头发性短暂症和低体温。